
Background Leprosy remains a chronic infectious disease that can lead to significant disabilities if not diagnosed early. In Iraq, it is considered a low-incidence, sporadic disease. This study aims to evaluate the performance of the recently revised Iraqi national surveillance plan. Methods A retrospective, descriptive case-series study, conducted using the centralised registry of the National Leprosy Control Programme at the Iraqi Communicable Disease-Control Centre. All registered cases from January 2019 to September 2026 were included. Data on socio-demographic characteristics, clinical classification (paucibacillary vs. multibacillary), and treatment outcomes were analysed using descriptive statistics via Microsoft Excel. Ethical approval was obtained, and patient confidentiality was maintained. Results Among the 8 registered cases, 100% were clinically classified as multibacillary (MB) leprosy, with laboratory confirmation, during 2019–2026. Regarding sex, 6 (75%) were males. Among all patients, one case was less than 15 years old, while 5 (62.5%) were within 15–59 years. Geographically, the highest proportion (3, 37.5%) was in Anbar Governorate. Regarding treatment outcomes, 4 (50%) of patients achieved complete clinical cure. Conclusion Leprosy in Iraq remains rarely detected and it requires sustained integrated surveillance, active case-finding, and enhanced training for healthcare workers.
Introduction Leprosy is a chronic infectious disease associated with significant social stigma and psychological distress. Anxiety and depression are common among individuals affected by leprosy but are often overlooked in routine care in Nepal. This study assesses the prevalence of anxiety and depression among leprosy patients and identifies associated factors. Methods A hospital-based cross-sectional study was conducted among 146 leprosy patients using systematic random sampling. Anxiety and depression symptoms were assessed using the GAD-7 and PHQ-9 scales, respectively. Data were entered into Epi-data 3.1 and analysed using SPSS 26. Result Around 50% had anxiety symptoms and 54% had depressive symptoms. In multivariable logistic regression analysis, illiteracy and higher diagnostic costs were independently associated with anxiety. Female sex, illiteracy and the presence of leprosy in the neighbourhood were independently associated with depression. Conclusion Anxiety and depression were highly prevalent among leprosy patients. Illiteracy and high diagnostic costs were key factors associated with anxiety, while female sex, illiteracy, and neighbourhood clustering of leprosy were associated with depression. These findings highlight the need to integrate routine mental health screening and psychosocial support into leprosy care services.
Objectives To map and synthesise the available evidence on financial toxicity among individuals affected by leprosy and to identify knowledge gaps relevant to health systems and social protection policies in endemic settings. Methods A scoping review following the Joanna Briggs Institute methodology and PRISMA-ScR guidelines was conducted (OSF: https://osf.io/pzf45). Searches were performed between March and April 2025 in seven databases (PubMed, Scopus, Embase, Cochrane, Web of Science, BDENF and LILACS) and grey literature sources (Science.gov, CAPES, Google Scholar, WorldCat and the National Portal of Electronic Theses and Dissertations). Eligible studies were original research published between 2015 and 2025 addressing economic burden, out-of-pocket expenditure, catastrophic health expenditure, income loss or other indicators of financial hardship, such as employment instability, productivity loss, food insecurity, housing vulnerability, indebtedness, and barriers to education, among people affected by leprosy. No restrictions were applied regarding study design or geographic setting. However, the studies included in the review were conducted in the following countries: Brazil, Ethiopia, India, Indonesia, Liberia, Mozambique, Nepal, and Uganda. Two reviewers independently screened and extracted data, which were synthesised descriptively to identify the main dimensions of financial toxicity and relevant knowledge gaps for health systems and social protection policies in endemic areas, defined as the constant presence or usual prevalence of a disease within a given geographic area or population. Results Sixteen studies met the inclusion criteria: seven qualitative (44%), three quantitative (19%) and six mixed-methods (37%). Studies assessed financial toxicity related to leprosy, defined as direct and indirect costs, out-of-pocket expenditure, income reduction and broader socioeconomic impacts using questionnaires, economic scales and qualitative analyses. Evidence consistently showed that people affected by leprosy face significant financial hardship, including out-of-pocket expenses, transport costs, work absenteeism and reduced earning capacity and barriers to accessing specialised services. Social stigma, physical disability and barriers to specialised services further increased economic vulnerability. Important knowledge gaps were identified regarding standardised measures of financial toxicity, health-system responses and social protection strategies in endemic settings. Conclusion Financial toxicity is a significant but underrecognised consequence of leprosy, extending beyond medical costs to lasting socioeconomic and psychosocial impacts. Integrating economic monitoring and social protection into leprosy control programmes may reduce financial vulnerability in endemic settings.
Objective To describe and understand how stigma affects the lives of individuals affected by Hansen's disease and to assess the effectiveness of interventions for preventing or addressing social stigma. Methods This prospective observational study enrolled 34 Hansen's patients attending a tertiary-care dermatology clinic. The study was based on mixed methods. Quantitative data concerning social stigma were assessed using the Stigma Assessment and Reduction of Impact (SARI) questionnaire scale, while descriptive data used simple and self-explanatory pre-validated questionnaires that measured the effectiveness of stigma-reduction interventions such as counselling, socioeconomic development (SED), and contact. Quantitative variables were expressed as means and SDs. Qualitative data were expressed as percentages or proportions. Suitable statistics were applied, based on the distribution of data. Results Calculated SARI domain means showed disclosure concerns were most prominent (4.00 +/- 3.06), followed by internalized stigma (2.94 +/- 2.53), experienced stigma (0.88 +/- 1.67), and anticipated stigma (0.15 +/- 0.36); the total mean of SARI scores was 7.97 +/- 5.79. On interventions: 27/34 (79%) patients knew the meaning of counselling, 23/34 (68%) had received disease-related counselling, but only 6/34 (18%) had received counselling addressing behavior/self-esteem; 16/34 (47%) participated in contact activities; 12/34 (35%) were involved in SED-related social interactions, and 9/34 (26%) had received financial aid from NGOs. The results demonstrate substantial concern about disclosure coupled with incomplete provision of psychosocial and livelihood support. Conclusion In this study disclosure-related stigma predominated, while implementation of counselling, SED, and contact interventions was inconsistent. Strengthening delivery and evaluation of the three key intervention pillars is essential to mitigate stigma and improve comprehensive care for Hansen's patients.
Background Ethiopia contributes 1.3 degrees'c (n = 2500) of the estimated global annual incidence of leprosy, a stigmatising neglected tropical disease. Mycobacterium leprae (M. leprae) is non-cultivable on artificial media, challenging diagnosis and research. Diagnostic challenges include low sensitivity of acid-fast bacilli (AFB) microscopy in paucibacillary (PB) cases and variability in immunologic tests. To improve detection, this study evaluated real-time PCR (qPCR) targeting the RLEP region of M. leprae in slit skin smear (SSS) samples. Methods A cross-sectional study conducted from October 2023 to February 2024 examined 124 SSS samples from individuals with clinical leprosy and 12 controls without a history of the disease. Quantitative PCR (qPCR) was performed using SYBR Green chemistry. Statistical analyses are carried out utilising MedCalc to determine sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and 95 degrees'c confidence intervals. A significance level of p <= 0.05 was adopted for all analyses. Results Among 124 patients with clinically diagnosed leprosy, 89 (71.8 degrees'c) were confirmed positive through histopathology, while 35 (28.2 degrees'c) were negative. When evaluated against clinical diagnosis, qPCR demonstrated a sensitivity of 91.1 degrees'c (95 degrees'c CI: 84.7-95.4 degrees'c) and a specificity of 100 degrees'c (95 degrees'c CI: 73.5-100 degrees'c). Using histopathology as a reference standard, qPCR showed a sensitivity of 95.5 degrees'c (95 degrees'c CI: 88.9-98.8 degrees'c). A significant correlation was observed between qPCR and histopathological findings (chi 2 = 28.052, P < 0.0001). All negative control samples (n = 12) and specimens of other mycobacteria tested negative by qPCR, indicating the assay's high analytical specificity. Conclusion The qPCR exhibits high sensitivity and a strong correlation with histopathology, while agreement with the clinical diagnosis is excellent. Nonetheless, multicenter studies are necessary to further confirm its accuracy and reproducibility in diverse geographic regions before it can be widely adopted in clinical practice.